Nature Communications (Jan 2022)

Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome

  • Carlo Cervia,
  • Yves Zurbuchen,
  • Patrick Taeschler,
  • Tala Ballouz,
  • Dominik Menges,
  • Sara Hasler,
  • Sarah Adamo,
  • Miro E. Raeber,
  • Esther Bächli,
  • Alain Rudiger,
  • Melina Stüssi-Helbling,
  • Lars C. Huber,
  • Jakob Nilsson,
  • Ulrike Held,
  • Milo A. Puhan,
  • Onur Boyman

DOI
https://doi.org/10.1038/s41467-021-27797-1
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 12

Abstract

Read online

Studying a prospective cohort, the authors develop and validate a predictive score for post-acute COVID-19 syndrome, also known as long-COVID. This score relies on an immunoglobulin signature and is independent of timepoint of blood sampling.